• Acetylcholine Chloride in Cholinergic Research

  2026-09-03

  Acetylcholine Chloride is a defined acetylcholine neurotransmitter source for receptor, neuromuscular junction, autonomic, and gut-brain studies. Its documented identity, solubility, and storage parameters support controlled acetylcholine receptor activation, while the 2026 Bacteroides fragilis study connects cholinergic signaling with antiseizure research.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-02

  Jonas, Plant, and Henquin showed that several imidazoline α2-adrenoceptor antagonists stimulate insulin release primarily by inhibiting ATP-sensitive K+ channels in mouse pancreatic β-cells, rather than through adrenoceptor blockade alone. Their combined use of 86Rb efflux, whole-cell patch clamp, glucose stimulation, and pharmacological rescue experiments provides a useful framework for distinguishing receptor-mediated effects from direct ion-channel actions.

• Lanabecestat (AZD3293) BACE1 Assay Workflow

  2026-09-02

  Build a translational Alzheimer’s disease research workflow around Lanabecestat (AZD3293), linking amyloid-beta production inhibition to functional synaptic measurements. The approach emphasizes partial BACE1 enzyme inhibition, controlled exposure, and assay troubleshooting rather than relying on a single potency readout.

• Fosinopril sodium in Reliable Cell Assays

  2026-09-01

  A scenario-based guide to using Fosinopril sodium in cell viability, proliferation, and cytotoxicity workflows. It explains how SKU A4079 supports better vehicle control, stock preparation, assay interpretation, and vendor selection without confusing ACE inhibition potency with a direct cellular viability effect.

• EZ Cap™ Firefly Luciferase mRNA in LNP Assays

  2026-09-01

  EZ Cap™ Firefly Luciferase mRNA can serve as more than a reporter: it is a practical probe for separating delivery, endosomal release, translation, and cell-state effects. This article connects Cap 1 biology with lipid nanoparticle process variables and assay interpretation.

• EDTA-Free Protease and Phosphatase Inhibitor Cocktail

  2026-08-31

  K4006 is a 100X, EDTA-free aqueous cocktail for limiting proteolysis and dephosphorylation during extraction or lysis of cells, tissues, yeast, and bacteria. It is appropriate when metal chelation is undesirable, but it should not be treated as a substitute for EDTA in workflows that specifically require chelation or as a guarantee of complete inhibition.

• Ganetespib: Hsp90 Strategy Beyond Oncogenic Clients

  2026-08-30

  A translational framework for using Ganetespib (STA-9090) to connect Hsp90 client-protein degradation, tumor growth inhibition, and emerging insights into regulated cell death and selective protein release.

• Sodium salicylate in stromal inflammation assays

  2026-08-29

  Sodium salicylate provides a practical NF-κB inhibitor workflow for separating inflammatory signaling from the physical barriers that limit pancreatic tumor drug delivery. Its high water solubility and defined handling profile make it useful for cell, co-culture, and nanomedicine-supporting assays.

• SIS3: A Translational Lens on Smad3 Biology

  2026-08-29

  SIS3 offers translational researchers a focused way to interrogate Smad3 within the TGF-β signaling pathway. This thought-leadership article connects its mechanism and product characteristics with evidence from osteoarthritis, fibrosis research, renal fibrosis models, and diabetic nephropathy research while outlining a disciplined path from target engagement to preclinical decision-making.

• Anti-ROR1 Antibody (Zilovertamab) Workflow Guide

  2026-08-28

  Build reproducible ROR1 binding, flow cytometry, and functional assays with a humanized IgG1 designed to block Wnt5a-induced ROR1 signaling. This guide also translates pathway-validation lessons from a liver-injury study into practical controls without confusing toxicology evidence with oncology validation.

• Elobixibat Hydrate: From IBAT to Peristalsis

  2026-08-28

  Elobixibat hydrate is an ileal bile acid transporter inhibitor whose value extends beyond bile acid recycling to measurable changes in intestinal propulsion. This article connects its enterohepatic mechanism with a rigorously designed guinea-pig peristalsis model to guide translational assay selection.

• 2,2,2-Trichloroethanol: An Assay Decision Guide

  2026-08-27

  Explore how 2,2,2-Trichloroethanol supports protein-focused workflows and how assay readouts should be selected in translational neurobiology. This evidence-aware guide separates product capabilities from findings in dopamine transporter imaging research.

• Antiseptics for Burns: Evidence and Research Implications

  2026-08-27

  This Cochrane review synthesized randomized evidence on antiseptic strategies for burn wounds, including silver dressings and topical antibiotics. Its central contribution was to show that available comparisons provide limited, low- or very-low-certainty evidence for differences in healing, infection, pain, or adverse events, highlighting the need for better-designed trials.

• Praeruptorin A: Applied Research Workflows

  2026-08-26

  Praeruptorin A supports integrated ferroptosis, inflammation, barrier-function, cardiomyopathy, and metastasis studies rather than single-endpoint screening. This guide translates its multi-target biology into practical dose-finding, pathway-validation, combination, and troubleshooting workflows.

• From CAF Signaling to Actionable Protein Workflows

  2026-08-26

  A translational framework for connecting CAF-driven ANGPTL4-IQGAP1 signaling with reproducible, non-denaturing protein extraction for Western blotting, immunoprecipitation, and mechanistic tumor microenvironment studies.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page